Study shows benefits of CGM in adults with diabetes who take multiple daily injections
News-Medical.net DexCom, Inc., the leader in continuous glucose monitoring (CGM) for people with diabetes, is presenting important clinical data for patients with type 1 and type 2 diabetes, at the American Diabetes Association's 77th Scientific Sessions, June 9-13 in ... |
Social Plugin